Shopping Cart
- Remove All
- Your shopping cart is currently empty
Eblasakimab (ASLAN004) is a humanized monoclonal antibody targeting the IL-13 receptor alpha. By blocking IL-4 and IL-13 signaling through type 2 receptor inhibition, it can be used for studying atopic dermatitis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $197 | In Stock | |
5 mg | $562 | In Stock | |
10 mg | $882 | In Stock | |
25 mg | $1,330 | In Stock | |
50 mg | $1,780 | In Stock |
Description | Eblasakimab (ASLAN004) is a humanized monoclonal antibody targeting the IL-13 receptor alpha. By blocking IL-4 and IL-13 signaling through type 2 receptor inhibition, it can be used for studying atopic dermatitis. |
In vitro | Eblasakimab is an interleukin (IL) -13 receptor alpha1 antagonist that blocks IL-4 and IL-13 signaling through type 2 receptors. [1] |
Alias | CSL-334, CSL334, ASLAN004, ASLA N004 |
Cas No. | 2445460-16-0 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.